Key result
Dietary nitrate enhances post-ischemic cardiomyocyte contractility without altering Ca2+ transients.
Why the study?
Although dietary nitrate supplementation confers cardioprotection by enhancing nitric oxide availability, the mechanisms underlying its direct effects on cardiomyocytes after ischemic injury and the potential role of circulating cardioprotective factors remain incompletely understood.
Does dietary inorganic nitrate or plasma from high-nitrate beetroot juice intake improve cardiomyocyte contractile performance and Ca²⁺ homeostasis in mouse models of post-MI HFrEF and ex vivo ischemia/reperfusion injury?
Does dietary inorganic nitrate or plasma from high-nitrate beetroot juice intake improve cardiomyocyte contractile performance and Ca²⁺ homeostasis in mouse models of post-MI HFrEF and ex vivo ischemia/reperfusion injury?
Dietary inorganic nitrate enhances cardiomyocyte contractility after ischemic injury via intercellular cross-talk, accelerated sarcoplasmic reticulum Ca²⁺ reuptake, and myofilament modifications without altering Ca²⁺ transient amplitude, suggesting a potential therapeutic mechanism for high-risk populations such as women with preeclampsia.
Answers are grounded in this paper and cite their sources.
May enhance contractility in HFrEF models; leaves open clinical translation to human therapy.
Background Reduced nitric oxide (NO) bioavailability is a hallmark of impaired cardiovascular function after ischemic injury and in heart failure. Preeclampsia is associated with a markedly increased long-term risk of cardiovascular disease, with approximately a twofold higher incidence of ischemic heart disease compared to normotensive pregnancies. Strategies restoring NO signaling may therefore be particularly relevant in this high-risk population. Dietary inorganic nitrate is a promising approach to enhance systemic NO availability and improve cardiac performance. Although nitrate supplementation confers cardioprotection, the mechanisms underlying its direct effects on cardiomyocytes and the potential role of circulating cardioprotective factors remain incompletely understood. Purpose We investigated whether dietary nitrate induces intercellular cross-talk capable of modulating cardiomyocyte contractility and Ca²⁺ homeostasis after ischemic injury. We hypothesized that inorganic nitrate enhances contractile performance through NO-mediated mechanisms and circulating protective factors. Methods Myocardial infarction (MI) was induced in mice to generate HFrEF. Animals received dietary nitrate or control diet for 4–6 weeks. Cardiomyocytes were isolated from post-MI hearts to assess fractional shortening and Ca²⁺ transients. To evaluate circulating mediators, an ex vivo ischemia/reperfusion (I/R) model was used. Cardiomyocytes from naïve mice were subjected to I/R and incubated with plasma from patients randomized to high-nitrate beetroot juice intake or placebo, including women with preeclampsia. Contractility and Ca²⁺ signaling were analyzed. Inflammatory, oxidative stress, and contractile markers were assessed by qPCR and Western blot. Results Cardiomyocytes from nitrate-treated HFrEF mice showed significantly enhanced contractility versus controls without changes in Ca²⁺ transient amplitude, while sarcoplasmic reticulum Ca²⁺ reuptake was accelerated. In the ex vivo I/R model, plasma from high-nitrate intake patients improved contractility of injured cardiomyocytes compared with placebo plasma, again without affecting Ca²⁺ transient amplitude. Nitrate induced post-translational modifications of myofilament and Ca²⁺-handling proteins, enhancing cross-bridge efficiency and intracellular Ca²⁺ utilization. Inflammatory and oxidative stress markers were reduced in cardiomyocytes exposed to nitrate-derived plasma. Conclusions Dietary nitrate promotes cardioprotection through intercellular cross-talk mechanisms that enhance contractile performance independently of major changes in Ca²⁺ transient amplitude. Improved Ca²⁺ handling kinetics and myofilament efficiency, together with circulating protective factors, contribute to functional recovery after ischemic injury. Targeting NO-mediated communication may represent a therapeutic strategy, particularly in high-risk populations such as women with preeclampsia.
No takes yet. Share an insight, caveat, or question.
Pironti et al. (2026) studied Heart failure with reduced ejection fraction (HFrEF), ischemic/reperfusion injury, and preeclampsia. Dietary inorganic nitrate / high-nitrate beetroot juice plasma vs. Control diet or placebo plasma was evaluated on Cardiomyocyte contractility (fractional shortening) and Ca2+ homeostasis (Ca2+ transients). Dietary nitrate and plasma from high-nitrate intake patients significantly enhanced cardiomyocyte contractility after ischemic injury vs control/placebo without altering Ca2+ transient amplitude.
Synapse has enriched 10 related papers. Consider them for comparative context: